Stefan N. Constantinescu

Brussels Branch
Brussels, BRU, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 127 publications

Next-generation JAK inhibitors in the treatment of myeloproliferative neoplasms.

Next-generation JAK inhibitors in the treatment of myeloproliferative neoplasms.

Journal: Blood
Published: August 20, 2025

JCMM Annual Review on Advances in Biotechnology for the Treatment of Haematological Malignancies: A Review of the Latest In-Patient Developments 2024-2025.

JCMM Annual Review on Advances in Biotechnology for the Treatment of Haematological Malignancies: A Review of the Latest In-Patient Developments 2024-2025.

Journal: Journal of cellular and molecular medicine
Published: April 02, 2025

LIBX-A401: A Novel Selective Inhibitor of Acyl-CoA Synthetase Long Chain Family Member 4 (ACSL4) and Its Binding Mode.

LIBX-A401: A Novel Selective Inhibitor of Acyl-CoA Synthetase Long Chain Family Member 4 (ACSL4) and Its Binding Mode.

Journal: Angewandte Chemie (International ed. in English)
Published: January 07, 2025

Oxazolidinone antibiotics impair ex vivo megakaryocyte differentiation from hematopoietic progenitor cells and their maturation into platelets.

Oxazolidinone antibiotics impair ex vivo megakaryocyte differentiation from hematopoietic progenitor cells and their maturation into platelets.

Journal: Antimicrobial agents and chemotherapy
Published: September 19, 2024

Delineating Mpl-dependent and -independent phenotypes of Jak2 V617F-positive MPNs in vivo.

Delineating Mpl-dependent and -independent phenotypes of Jak2 V617F-positive MPNs in vivo.

Journal: Blood
Published: August 26, 2024

Musculoskeletal diseases, infections and vaccines: state of the art, research perspectives and educational needs.

Musculoskeletal diseases, infections and vaccines: state of the art, research perspectives and educational needs.

Journal: Aging clinical and experimental research
Published: August 16, 2024

Increased RhoA pathway activation downstream of αIIbβ3/SRC contributes to heterozygous Bernard Soulier syndrome.

Increased RhoA pathway activation downstream of αIIbβ3/SRC contributes to heterozygous Bernard Soulier syndrome.

Journal: Haematologica
Published: August 09, 2024

Dominance of mutations in epigenetic regulators and a diversity of signaling alterations in blast-phase BCR::ABL1-negative myeloproliferative neoplasms.

Dominance of mutations in epigenetic regulators and a diversity of signaling alterations in blast-phase BCR::ABL1-negative myeloproliferative neoplasms.

Journal: American journal of hematology
Published: July 29, 2024

DNMT3A gates IFN-induced MPN HSC exhaustion.

DNMT3A gates IFN-induced MPN HSC exhaustion.

Journal: Blood
Published: June 13, 2024

Novel germline JAK2R715T mutation causing PV-like erythrocytosis in 3 generations. Amelioration by Ropeg-Interferon.

Novel germline JAK2R715T mutation causing PV-like erythrocytosis in 3 generations. Amelioration by Ropeg-Interferon.

Journal: American journal of hematology
Published: March 20, 2024

Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.

Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.

Journal: Genome medicine
Published: January 06, 2024

Chromothripsis orchestrates leukemic transformation in blast phase MPN through targetable amplification of DYRK1A.

Chromothripsis orchestrates leukemic transformation in blast phase MPN through targetable amplification of DYRK1A.

Journal: bioRxiv : the preprint server for biology
Published: December 18, 2023
Showing 1-12 of 127

Last Updated: 09/26/2026